QMENTA launches Central Review to address the longitudinal consistency problem that derails long-duration oncology and CNS trials
Discover what's new in QMENTA Platform 4.2, including preserved manual workflows, improved DICOM performance, modern authentication, audit logging,...
Conversations at ISMRM 2026 revealed growing challenges around imaging data sharing, interoperability, federated learning, and scalable MRI research...
Clinical operations leaders are not prepared for the downstream impact of GPT-Rosalind. Explore the hidden trial infrastructure risks of...
Compare QMENTA vs icometrix neuroimaging platforms: clinical trial infrastructure vs point-of-care diagnostics. Choose the right solution for MS...
Multi-site neuroimaging trials face protocol drift, QC bottlenecks, and audit gaps. A 2026 look at operational realities and what actually impacts...
QMENTA vs. Flywheel.io: Compare FDA-cleared CNS clinical AI vs. enterprise R&D infrastructure. See which medical imaging platform fits your trial.
QMENTA vs Medidata Rave Imaging: compare AI biomarkers, central review, imaging EDC, and which platform fits your clinical trial.
QMENTA Co-Founder Paulo Rodrigues shares observations from LSX World Congress Europe 2026: why biotech's bottleneck is execution, not science, and...